Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: August 16, 2022

Drug Price Trends for NDC 68682-0104

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Average Pharmacy Cost for 68682-0104

Subscribe to access the full database, or Sign up for a Free Trial
Drug Name	NDC	Price/Unit ($)	Unit	Date
OMEPRAZOLE-BICARB 40-1,100 CAP	68682-0104-30	0.97007	EACH	2021-06-23
OMEPRAZOLE-BICARB 40-1,100 CAP	68682-0104-30	1.28910	EACH	2021-05-19
OMEPRAZOLE-BICARB 40-1,100 CAP	68682-0104-30	1.46893	EACH	2021-04-21
OMEPRAZOLE-BICARB 40-1,100 CAP	68682-0104-30	1.43433	EACH	2021-03-17
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Best Wholesale Price for NDC 68682-0104

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Subscribe to access the full database, or Sign up for a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
OMEPRAZOLE 40MG/SODIUM BICARBONATE 1100MG CAP	Bausch Health US, LLC	68682-0104-30	30	150.75	5.02500	2019-01-01 - 2022-09-28	FSS
OMEPRAZOLE 40MG/SODIUM BICARBONATE 1100MG CAP	Bausch Health US, LLC	68682-0104-30	30	64.91	2.16367	2020-01-01 - 2022-09-28	Big4
OMEPRAZOLE 40MG/SODIUM BICARBONATE 1100MG CAP	Bausch Health US, LLC	68682-0104-30	30	150.75	5.02500	2020-01-01 - 2022-09-28	FSS
OMEPRAZOLE 40MG/SODIUM BICARBONATE 1100MG CAP	Bausch Health US, LLC	68682-0104-30	30	4.23	0.14100	2021-01-01 - 2022-09-28	Big4
>Drug Name	>Vendor	>NDC	>Count	>Price ($)	>Price/Unit ($)	>Dates	>Price Type

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

McKinsey

Harvard Business School

Moodys

Baxter

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.